Keros Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/13/2026 | 2.41 M | $26.63 M | 5.29% | 6.48% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.36 M | $15.02 M | 277.45% | 3.66% |
| 05/15/2026 | 831.42 K | $9.18 M | 100.00% | 2.23% | |
| ORBIMED ADVISORS LLC | 05/15/2026 | 759.16 K | $8.38 M | -5.60% | 2.04% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 724.93 K | $8.00 M | -7.53% | 1.95% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2026 | 706.07 K | $7.80 M | -8.11% | 1.90% |
| FEDERATED HERMES, INC. | 05/11/2026 | 689.23 K | $7.61 M | 5.27% | 1.85% |
| 05/08/2026 | 682.04 K | $7.53 M | 100.00% | 1.83% | |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 681.46 K | $7.52 M | 7.28% | 1.83% |
| MADISON AVENUE PARTNERS, LP | 05/15/2026 | 626.58 K | $6.92 M | -23.93% | 1.68% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 05/14/2026 | 590.25 K | $6.52 M | -55.77% | 1.59% |
| STATE STREET CORP | 05/15/2026 | 561.73 K | $6.20 M | -47.79% | 1.51% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 509.61 K | $5.63 M | -32.54% | 1.37% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 453.48 K | $5.01 M | -23.36% | 1.22% |
| CITADEL ADVISORS LLC | 05/15/2026 | 406.67 K | $4.49 M | -13.94% | 1.09% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2026 | 406.56 K | $4.49 M | 125.19% | 1.09% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 363.84 K | $4.02 M | 14.26% | 0.98% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 321.36 K | $3.55 M | 453.94% | 0.86% |
| NUVEEN, LLC | 04/30/2026 | 262.08 K | $2.89 M | 315.35% | 0.70% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/11/2026 | 257.88 K | $2.85 M | -19.75% | 0.69% |
| NORTHERN TRUST CORP | 05/14/2026 | 254.19 K | $2.81 M | 1.44% | 0.68% |
| MAN GROUP PLC | 05/15/2026 | 238.62 K | $2.63 M | 25.45% | 0.64% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 224.48 K | $2.48 M | -61.99% | 0.60% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2026 | 195.02 K | $2.15 M | 224.61% | 0.52% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 179.95 K | $1.99 M | -3.66% | 0.48% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 05/08/2026 | 172.20 K | $1.90 M | 409.89% | 0.46% |
| Y-INTERCEPT (HONG KONG) LTD | 04/27/2026 | 164.48 K | $1.82 M | 40.15% | 0.44% |
| MACKENZIE FINANCIAL CORP | 05/13/2026 | 152.45 K | $1.68 M | 196.68% | 0.41% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 151.04 K | $1.67 M | 361.02% | 0.41% |
| UBS GROUP AG | 05/05/2026 | 145.57 K | $1.61 M | 49.95% | 0.39% |
| EMPOWERED FUNDS, LLC | 06/16/2026 | 145.52 K | $1.61 M | 142.21% | 0.39% |
| BESSEMER GROUP INC | 05/06/2026 | 143.85 K | $1.59 M | 0.00% | 0.39% |
| CITADEL ADVISORS LLC | 05/15/2026 | 129.90 K | $1.43 M | -36.14% | 0.35% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 127.30 K | $1.41 M | 100.00% | 0.34% |
| MORGAN STANLEY | 05/15/2026 | 124.11 K | $1.37 M | -46.15% | 0.33% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 120.94 K | $1.34 M | -0.52% | 0.32% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 109.02 K | $1.20 M | 180.62% | 0.29% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 106.86 K | $1.18 M | -51.47% | 0.29% |
| AMERIPRISE FINANCIAL INC | 05/15/2026 | 102.48 K | $1.13 M | -16.57% | 0.28% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 97.32 K | $1.07 M | 416.25% | 0.26% |
| XTX TOPCO LTD | 05/15/2026 | 88.32 K | $975.08 K | 747.29% | 0.24% |
| INVESCO LTD. | 05/12/2026 | 87.77 K | $969.00 K | 0.39% | 0.24% |
| RUSSELL INVESTMENTS GROUP, LTD. | 05/08/2026 | 81.31 K | $897.68 K | 0.66% | 0.22% |
| HRT FINANCIAL LP | 05/14/2026 | 77.00 K | $850.00 K | -70.49% | 0.21% |
| ACADIAN ASSET MANAGEMENT LLC | 05/13/2026 | 65.44 K | $721.00 K | 100.00% | 0.18% |
| AMERICAN CENTURY COMPANIES INC | 05/15/2026 | 64.26 K | $709.43 K | 75.38% | 0.17% |
| RBF CAPITAL, LLC | 05/18/2026 | 62.80 K | $693.31 K | -23.16% | 0.17% |
| PRINCIPAL FINANCIAL GROUP INC | 05/04/2026 | 59.59 K | $657.92 K | 100.00% | 0.16% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 59.40 K | $655.78 K | -66.21% | 0.16% |
| RANGELEY CAPITAL, LLC | 05/15/2026 | 54.40 K | $600.58 K | -43.80% | 0.15% |
Keros Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 205 institutional investors and hedge funds held shares of Keros Therapeutics Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 2.41 M
Nantahala Capital Management, LLC: 1.36 M
ORBIMED ADVISORS LLC: 759,155
Qube Research & Technologies Ltd: 724,926
JACOBS LEVY EQUITY MANAGEMENT, INC: 706,071
FEDERATED HERMES, INC.: 689,229
49.96% of Keros Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 22.15 M shares in the last 24 months. This purchase volume represents approximately $251.42 M in transactions.